|
REFERENCE TITLE: cancer treatment medications; equivalent cost-sharing |
|
State of Arizona Senate Fifty-first Legislature Second Regular Session 2014
|
|
SB 1247 |
|
|
|
Introduced by Senators Driggs, Tovar; Representatives Brophy McGee, Campbell, Carter, Gonzales, Gowan, Meyer, Townsend: Senator Barto; Representatives Boyer, Steele
|
AN ACT
Amending title 20, chapter 4, article 3, Arizona Revised Statutes, by adding section 20‑841.10; Amending title 20, chapter 4, article 9, Arizona Revised Statutes, by adding section 20‑1057.14; Amending title 20, chapter 6, article 4, Arizona Revised Statutes, by adding section 20-1376.05; Amending title 20, chapter 6, article 5, Arizona Revised Statutes, by adding section 20-1406.06; relating to cancer treatment medications.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 20, chapter 4, article 3, Arizona Revised Statutes, is amended by adding section 20-841.10, to read:
20-841.10. Cancer treatment medications; cost‑sharing; definition
A. A contract that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.
B. A corporation may not comply with subsection A of this section by:
1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.
2. Reclassifying benefits with respect to cancer treatment medications.
C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.
Sec. 2. Title 20, chapter 4, article 9, Arizona Revised Statutes, is amended by adding section 20-1057.14, to read:
20-1057.14. Cancer treatment medications; cost‑sharing; definition
A. An evidence of coverage that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.
B. A health care services organization may not comply with subsection A of this section by:
1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.
2. Reclassifying benefits with respect to cancer treatment medications.
C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.
Sec. 3. Title 20, chapter 6, article 4, Arizona Revised Statutes, is amended by adding section 20-1376.05, to read:
20-1376.05. Cancer treatment medications; cost‑sharing; definition
A. A disability insurance policy that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.
B. A disability insurer may not comply with subsection A of this section by:
1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.
2. Reclassifying benefits with respect to cancer treatment medications.
C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.
Sec. 4. Title 20, chapter 6, article 5, Arizona Revised Statutes, is amended by adding section 20-1406.06, to read:
20-1406.06. Cancer treatment medications; cost‑sharing; definition
A. A group or blanket disability policy that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.
B. A group or blanket disability insurer may not comply with subsection A of this section by:
1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.
2. Reclassifying benefits with respect to cancer treatment medications.
C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.
Sec. 5. Short title
This act may be cited as the "Fair Access to Cancer Treatment Act".